Strategic, innovative, and performance-driven leader with 15+ years’ experience in the pharmaceutical & consumer health industries and a proven track record of growing business revenue through program development and operational success by inspiring innovation, developing and optimizing plans, aligning key stakeholders for execution and delivering commercially meaningful results through clear dissemination and communication of asset value.Comprehensive understanding of the macro health care systems & the bench-to-shelf continuum of pharmaceutical drug development & commercial operations. Expertise in various payor (including 'consumer as payor') areas including value propositions, health economics, outcomes research, PRO development, epidemiology, market access and reimbursement with a proven track record of leading global cross-cultural, cross-functional teams in multiple therapeutic areas.Worked within and lead global HEOR & Market Access Teams in various leading pharmaceutical companies and consultancies across various geographies (US, UK, EU, APAC, MENA) on various assets/therapy areas (Oncology, Rare Diseases, GI, CNS, Diabetes, CV, Cystic Fibrosis)